An 88-year-old 
Introduction

Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic anemia in which pathologic antibodies destroy erythrocytes. Various diseases and conditions are responsible for the development of AIHA including viral infection, autoimmune disease, immune deficiency status, lymphoproliferative disorders, other malignancies, drugs and so on. Here, we report a man AIHA patient accompanied by reactivation of Epstein-Barr virus (EBV). EBV is a human disease pathogen which is especially common in Asian countries including Japan. Almost 90% of people acquire the viral infection during their childhood or adolescence (1). Once infected, the infection persists and becomes latent in B-cells. If the immune system is suppressed by transplantation, lymphoma, or HIV infection, EBV is reactivated and can cause lymphoproliferative disorders (LPD) (2). Recently, Oyama and colleagues evaluated EBV-associated B-cell LPD and speculated that EBV can be reactivated by age-related immunological deterioration resulting in LPD, which they called age-related EBV-associated B-cell LPD (3). The disorder now is defined as EBV-positive diffuse large B-cell lymphoma of the elderly according to the new World Health Organization (WHO) classification (4). However there had been no report proving suppressed EBV-specific cytotoxic T cell (CTL) activity in such patients.
A primary EBV infection is known to cause AIHA (5 
Materials and Methods
A sample from a patient with infectious mononucleosis (IM) was used as control to measure CTL activity. CD8 -p o s i t i v e c e l l s o f t h e p r e s e n t p a t i e n t .  S p o t s we r e s i g n i f i c a n t l y d e c r e a s e d i n D c o mp a r e d t o B . Vi r a l L a b o r a t o r y F i n d i n g s o n Ad mi s s i o 
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